from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3451/cut3

LFCtreatmentdescriptionclass of inhibitor

0.240

Amikacinug/mL Amikacintranslation

1.225

Cap5-10ug/mL Capreomycintranslation

1.708

Rox10-50 ug/mL Roxithromycintranslation

0.547

SM2-5 ug/mL Streptomycintranslation

1.426

Tet5-10 ug/mL Tetracyclinetranslation

-0.657

Rif0.2-5ug/mL Rifampicintranscription

-0.506

Rifp0.1-0.5ug/mL Rifapentinetranscription

-2.098

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.800

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.386

CPZ10-50 ug/mL Chlorpromazinerespiration

0.291

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.386

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.417

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.368

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.507

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.292

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.159

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.603

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.901

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.972

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.936

KCN5-20 ug/mL Potassium cyaniderespiration

0.177

NaN30.2-2 mM Sodium aziderespiration

1.043

Nigericin50 uM Nigericinrespiration

0.025

TRC10-150 ug/mL Triclosanrespiration

1.330

TRZ10-25 ug/mL Thioridazinerespiration

2.880

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.709

menadione6-10 ug/mL Menadionerespiration

0.175

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.444

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.326

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.177

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.501

NRP_1Non-replicating persistence stage 1dosRassociated

-0.190

Amp0.2mg/mL AmpicillincellWall

-0.298

Cephalexin20-100 ug/mL CephalexincellWall

0.536

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.439

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.381

EMB10-20 ug/mL EthambutolcellWall

-0.155

Eta12-40 ug/mL EthionamidecellWall

-0.483

INH0.2-0.4 ug/mL IsoniazidcellWall

0.359

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.653

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.141

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.226

BZA0.12 mg/mL BenzamidearomaticAmides

0.053

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.432

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.726

H2O24 mM hydrogen peroxideDNAdamaging

0.467

Levo10 ug/mL LevofloxacinDNAdamaging

-0.655

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.813

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.393

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.455

UVUV-irradiationDNAdamaging

2.266

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.570

Antimycin12.5-50 ug/mL Antimycin A?

0.006

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.020

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.467

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.749

PA8240.2-2 ug/mL PA-824?

1.066

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.261

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.085

Verapamil50 uM Verapamil?

-0.049

mercaptoethanol2 mM 2-Mercaptoethanol?

0.248

methoxatin10-20 ug/mL Methoxatin?